Park, Jae Hyun,Woo, Jong Soo,Kim, Yong Il,Na, Young Jun,Kim, Min Jung,Kim, Young-Hun
申请号：
AU2016203739
公开号：
AU2016203739B2
申请日:
2016.06.03
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2016203739B220171102.pdf#####ABSTRACT Provided is a pharmaceutical formulation in the form of bilayered tablets consisting of a first layer containing irbesartan or pharmaceutically acceptable salts thereof and a second layer containing an HMG-CoA reductase inhibitor and a basic additive, which can improve the dissolution rate and stability of irbesartan and an HMG-CoA reductase inhibitor to enhance the bioavailability of the drug compared to conventional complex formulations and to minimize the generation of the related compounds, thereby being effectively used as a stable and superior therapeutic agent for hypertension and hypercholesterolemia.
